Umirolimus

This classification denotes an immunosuppressant with the molecular formula C55H87NO14, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) U36PGF65JH, chemically known as rapamycin, 42-o-(2-ethoxyethyl)- but more generally known as umirolimus, which bears US NIH Compound Identifier 11158972. European Medicines Agency schedules umirolimus in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB33179. The term UMIROLIMUS is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 25, No. 1, 2011, List 64). As of Q4 2014, UMIROLIMUS remains US FDA's Preferred Term for this commodity. Most nations, for tariff and trade purposes, schedule UMIROLIMUS under HS 29349990 and SITC 51579. SMILES: CCOCCOC1CCC(CC1OC)CC(C)C2CC(=O)C(C=C(C(C(C(=O)C(CC(C=CC=CC=C(C(CC3CCC(C(O3)(C(=O)C(=O)N4CCCCC4C(=O)O2)O)C)OC)C)C)C)OC)O)C)C.